Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE.
Neville LF, Gnatt A, Loewenstein Y, Seidman S, Ehrlich G, Soreq H.
???displayArticle.abstract???
Structure-function relationships of cholinesterases (CHEs) were studied by expressing site-directed and naturally occurring mutants of human butyrylcholinesterase (BCHE) in microinjected Xenopus oocytes. Site-directed mutagenesis of the conserved electronegative Glu441,Ile442,Glu443 domain to Gly441,Ile442,Gln443 drastically reduced the rate of butyrylthiocholine (BTCh) hydrolysis and caused pronounced resistance to dibucaine binding. These findings implicate the charged Glu441,Ile442,Glu443 domain as necessary for a functional CHE catalytic triad as well as for binding quinoline derivatives. Asp70 to Gly substitution characteristic of 'atypical' BCHE, failed to alter its Km towards BTCh or dibucaine binding but reduced hydrolytic activity to 25% of control. Normal hydrolytic activity was restored to Gly70 BCHE by additional His114 or Tyr561 mutations, both of which co-appear with Gly70 in natural BCHE variants, which implies a likely selection advantage for these double BCHE mutants over the single Gly70 BCHE variant. Gly70 BCHE variants also displayed lower binding as compared with Asp70 BCHE to cholinergic drugs, certain choline esters and solanidine. These effects were ameliorated in part by additional mutations or in binding solanidine complexed with sugar residues. These observations indicate that structural interactions exist between N' and C' terminal domains in CHEs which contribute to substrate and inhibitor binding and suggest a crucial involvement of both electrostatic and hydrophobic domains in the build-up of the CHE active center.
Ben Aziz,
Improving poor in vitro transcription from G,C-rich genes.
1990, Pubmed
Ben Aziz,
Improving poor in vitro transcription from G,C-rich genes.
1990,
Pubmed Berman,
Fluorescent phosphonate labels for serine hydrolases. Kinetic and spectroscopic properties of (7-nitrobenz-2-oxa-1,3-diazole)aminoalkyl methylphosphonofluoridates and their conjugates with acetylcholinesterase molecular forms.
1985,
Pubmed Brady,
A serine protease triad forms the catalytic centre of a triacylglycerol lipase.
1990,
Pubmed Brennan,
Hypermutability of CpG dinucleotides in the propeptide-encoding sequence of the human albumin gene.
1990,
Pubmed Cohen,
1-Bromopinacolone, an active site-directed covalent inhibitor for acetylcholinesterase.
1982,
Pubmed Gibney,
Mutagenesis of essential functional residues in acetylcholinesterase.
1990,
Pubmed Gnatt,
Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.
1990,
Pubmed HARRIS,
Differential inhibition of the serum cholinesterase phenotypes by solanine and solanidine.
1962,
Pubmed Hasan,
Cationic and uncharged substrates and reversible inhibitors in hydrolysis by acetylcholinesterase (EC 3.1.1.7). The trimethyl subsite.
1981,
Pubmed Hasan,
Hydrolysis by acetylcholinesterase. Apparent molal volumes and trimethyl and methyl subsites.
1980,
Pubmed HODGKIN,
COMPLETE PSEUDOCHOLINESTERASE DEFICIENCY: GENETIC AND IMMUNOLOGIC CHARACTERIZATION.
1965,
Pubmed Kragh-Hansen,
Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
1990,
Pubmed Kunkel,
Rapid and efficient site-specific mutagenesis without phenotypic selection.
1987,
Pubmed La Du,
Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.
1991,
Pubmed Lapidot-Lifson,
Coamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesis.
1989,
Pubmed Layer,
Spatiotemporal relationship of embryonic cholinesterases with cell proliferation in chicken brain and eye.
1987,
Pubmed Lockridge,
Location of disulfide bonds within the sequence of human serum cholinesterase.
1987,
Pubmed MacPhee-Quigley,
Profile of the disulfide bonds in acetylcholinesterase.
1986,
Pubmed Majumdar,
Chemical modification of acetylcholinesterase from eel and basal ganglia: effect on the acetylcholinesterase and aryl acylamidase activities.
1984,
Pubmed Naveh,
New substrates of acetylcholinesterase.
1981,
Pubmed Neville,
Aspartate-70 to glycine substitution confers resistance to naturally occurring and synthetic anionic-site ligands on in-ovo produced human butyrylcholinesterase.
1990,
Pubmed
,
Xenbase Neville,
Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.
1990,
Pubmed
,
Xenbase Nolte,
Effective charge on acetylcholinesterase active sites determined from the ionic strength dependence of association rate constants with cationic ligands.
1980,
Pubmed Page,
Acetylcholinesterase: inhibition by tetranitromethane and arsenite. Binding of arsenite by tyrosine residues.
1985,
Pubmed Patinkin,
Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro.
1990,
Pubmed
,
Xenbase Piela,
Proline-induced constraints in alpha-helices.
1987,
Pubmed Prody,
Isolation and characterization of full-length cDNA clones coding for cholinesterase from fetal human tissues.
1987,
Pubmed Russell,
Rational modification of enzyme catalysis by engineering surface charge.
,
Pubmed Russell,
Electrostatic effects on modification of charged groups in the active site cleft of subtilisin by protein engineering.
1987,
Pubmed Sali,
Stabilization of protein structure by interaction of alpha-helix dipole with a charged side chain.
1988,
Pubmed Shinitzky,
Spectral evidence for the presence of tryptophan in the binding site of acetylcholinesterase.
1973,
Pubmed Soreq,
Expression and tissue-specific assembly of human butyrylcholine esterase in microinjected Xenopus laevis oocytes.
1989,
Pubmed
,
Xenbase Sussman,
Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein.
1991,
Pubmed Valentino,
Prediction of drug sensitivity in individuals with atypical serum cholinesterase based on in vitro biochemical studies.
1981,
Pubmed Weise,
Anionic subsites of the acetylcholinesterase from Torpedo californica: affinity labelling with the cationic reagent N,N-dimethyl-2-phenyl-aziridinium.
1990,
Pubmed Winkler,
Structure of human pancreatic lipase.
1990,
Pubmed Zakut,
Polymorphism of acetylcholinesterase in discrete regions of the developing human fetal brain.
1985,
Pubmed
,
Xenbase Zakut,
Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas.
1990,
Pubmed
,
Xenbase Zakut,
Chorionic villus cDNA library displays expression of butyrylcholinesterase: putative genetic disposition for ecological danger.
1991,
Pubmed Zhang,
Toward a simplification of the protein folding problem: a stabilizing polyalanine alpha-helix engineered in T4 lysozyme.
1991,
Pubmed
